BABA vs ZYME · P/E 20, rev $137.30B vs rev $76.3M
Alibaba Group Holding Ltd (BABA) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the BABA and ZYME stock pages for the full models.
Not investment advice.